World's Best Scientists 2026 revealed!
Margarita Sánchez-Beato

Margarita Sánchez-Beato

D-Index & Metrics

Biology and Biochemistry

D-Index
49
Citations
6673
World Ranking
18144
National Ranking
412

Overview

Margarita Sánchez-Beato is affiliated with the Instituto de Salud Carlos III in Spain. Their research spans multiple disciplines within medicine and the life sciences, with a particular emphasis on oncology, molecular biology, pathology, and immunology. The scientist has contributed extensively to the understanding of lymphoma and related hematological malignancies.

Their work frequently addresses topics such as lymphoma diagnosis and treatment, ubiquitin and proteasome pathways, viral-associated cancers and disorders, chronic lymphocytic leukemia, CAR-T cell therapy, cutaneous lymphoproliferative disorders, and cancer genomics and diagnostics.

Recent publications authored or coauthored by Sánchez-Beato include the following:

  • Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial (2021, Journal for ImmunoTherapy of Cancer)
  • Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers (2021, Blood Advances)
  • Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma (2021, Scientific Reports)
  • Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study (2022, Clinical Cancer Research)
  • Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides: a single-arm, multicentre, phase 2 trial (2022, The Lancet Haematology)

Collaborations are a significant aspect of Sánchez-Beato's research activities. Frequent coauthors include Ismael Fernández-Miranda, Paloma Martín, Mariano Provencio, Miguel Á. Piris, and Juan F. García.

Their research has been published in various journals, with multiple contributions in the following venues:

  • Cancers
  • Blood
  • European Journal of Cancer
  • Hematological Oncology
  • Clinical Cancer Research

The scientist's main fields of study comprise Medicine and Biochemistry, Genetics, and Molecular Biology. Within these fields, Sánchez-Beato focuses on subfields such as Pathology and Forensic Medicine, Oncology, Immunology, Cancer Research, and Molecular Biology. These areas support a research profile strongly oriented towards both clinical and molecular aspects of cancer, particularly lymphomas.

Best Publications

  • Cell cycle deregulation in B-cell lymphomas.

    Margarita Sánchez-Beato;Abel Sánchez-Aguilera;Miguel A. Piris

  • Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study

    Ken H Young;Karen Leroy;Michael Boe Møller;Gisele Wb Colleoni

  • p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time.

    M. A. Piris;F. Pezzella;J. C. Martinez-Montero;J. L. Orradre

  • PLCG1 mutations in cutaneous T-cell lymphomas.

    José P. Vaqué;Gonzalo Gómez-López;Verónica Monsálvez;Ignacio Varela

  • Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course.

    Patricia Algara;Marisol S. Mateo;Margarita Sanchez-Beato;Manuela Mollejo

  • Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.

    Manuel M. Morente;Miguel A. Piris;Victor Abraira;Agustin Acevedo

  • Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.

    Francisca I. Camacho;Manuela Mollejo;Maria-Sol Mateo;Patrocinio Algara

  • Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.

    Francisca I Camacho;Patrocinio Algara;Antonia Rodriguez;Elena Ruiz-Ballesteros

  • Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.

    Margarita Sánchez-Beato;Francisca I. Camacho;Juan C. Martı́nez-Montero;Ana I. Sáez

  • Loss of p16/INK4A Protein Expression in Non-Hodgkin's Lymphomas Is a Frequent Finding Associated with Tumor Progression

    Raquel Villuendas;Margarita Sánchez-Beato;Juan C. Martínez;Ana I. Saez

  • Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.

    Sánchez-Beato M;Sáez Ai;Martínez-Montero Jc;Sol Mateo M

  • Cancer induction by restriction of oncogene expression to the stem cell compartment

    María Pérez-Caro;César Cobaleda;Inés González-Herrero;Carolina Vicente-Dueñas

  • PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma

    Cristina Gómez-Abad;Helena Pisonero;Carmen Blanco-Aparicio;Giovanna Roncador

  • Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.

    Alberto J. Arribas;Yolanda Campos-Martín;Cristina Gómez-Abad;Patrocinio Algara

  • Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays.

    Margarita Sánchez-Beato;Esther Sánchez;Joaquín González-Carreró;Manuel Morente

  • The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas

    Lorena Di Lisio;Nerea Martinez;Santiago Montes-Moreno;Miguel Piris-Villaespesa

  • Overall Survival in Aggressive B-Cell Lymphomas Is Dependent on the Accumulation of Alterations in p53, p16, and p27

    Margarita Sanchez-Beato;Ana I. Saez;Inmaculada C. Navas;Patrocinio Algara

  • Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas

    Ana Isabel Sáez;Maria Jesús Artiga;Margarita Sánchez-Beato;Lydia Sánchez-Verde

  • Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.

    P. Jares;E. Campo;M. Pinyol;F. Bosch

  • p14ARF nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways

    Abel Sánchez-Aguilera;Margarita Sánchez-Beato;Juan F. Garcı́a;Ignacio Prieto

Frequent Co-Authors

Miguel A. Piris
Miguel A. Piris Instituto de Salud Carlos III
Santiago Montes-Moreno
Santiago Montes-Moreno Instituto de Investigación Marqués de Valdecilla
Gonzalo Gómez-López
Gonzalo Gómez-López Universidade de Vigo
Juan C. Cigudosa
Juan C. Cigudosa Instituto de Salud Carlos III
Elias Campo
Elias Campo University of Barcelona
Francesc Solé
Francesc Solé Autonomous University of Barcelona
James S. Malter
James S. Malter The University of Texas Southwestern Medical Center
Renato Franco
Renato Franco University of Campania "Luigi Vanvitelli"
Terry D. Oberley
Terry D. Oberley University of Wisconsin–Madison
Isidro Sánchez-García
Isidro Sánchez-García University of Salamanca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Biology or Biochemistry can open many doors in healthcare, research, and emerging technology fields. If you are interested in advancing your career or gaining specialized skills online, there are affordable options. For those interested in leadership, business, and health, the cheapest online mba healthcare management programs offer a practical route to managerial roles in the medical sector.

Another promising area is medical coding and billing. Careers as a certified coding specialist (CCS) are in high demand. If you want to understand the differences between credentials and what they mean for your career, see what it takes to become a certified coding specialist (ccs). Salaries for medical coders are competitive, and you can learn more about how much do medical coders make depending on your qualifications and experience.

Finally, if you are wondering whether to enter medical billing and coding, it is important to weigh all aspects of the profession. Learn about what makes is medical coding a good career to decide if this pathway matches your goals after studying Biology or Biochemistry.

Best Scientists Citing Margarita Sánchez-Beato

Trending Scientists